Targeting the duality of cancer
Abstract Cancer is the second leading cause of death in the United States, and is an increasing cause of death in the developing world. While there is great heterogeneity in the anatomic site and mutations involved in human cancer, there are common features, including immortal growth, angiogenesis,...
Guardado en:
Autores principales: | Jack L. Arbiser, Michael Y. Bonner, Linda C. Gilbert |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2017
|
Materias: | |
Acceso en línea: | https://doaj.org/article/aa257aec20b44654ad250b9c80ab252b |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Hyperleptinemia in obese state renders luminal breast cancers refractory to tamoxifen by coordinating a crosstalk between Med1, miR205 and ErbB
por: Arumugam Nagalingam, et al.
Publicado: (2021) -
MET targeted therapy for lung cancer: clinical development and future directions
por: Feng Y, et al.
Publicado: (2012) -
Emerging targeted combinations in the management of breast cancer
por: Lee RJ, et al.
Publicado: (2013) -
Targeting γ-secretase in breast cancer
por: Han J, et al.
Publicado: (2012) -
Inhibiting breast cancer by targeting the thromboxane A2 pathway
por: Haitao Li, et al.
Publicado: (2017)